OTOV-101

N/A

Report date: 2024/09/06 15:19:02

Base Information

Drug NameOTOV-101
Drug Alias NameOTOV101C+OTOV101NOTOV101N OTOV101COTOV-101
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionGene transference
TargetsOtoferlin
Therapy Area/IndicationsHearing Loss
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaClinical
Originator CompaniesSuzhou Otovia Therapeutics Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSuzhou Otovia Therapeutics Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsHearing Loss
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A